New Zealand markets closed
  • NZX 50

    11,065.15
    -37.69 (-0.34%)
     
  • NZD/USD

    0.6534
    +0.0051 (+0.79%)
     
  • NZD/EUR

    0.6089
    +0.0053 (+0.88%)
     
  • ALL ORDS

    7,413.10
    +73.80 (+1.01%)
     
  • ASX 200

    7,182.70
    +76.80 (+1.08%)
     
  • OIL

    114.70
    +0.61 (+0.53%)
     
  • GOLD

    1,851.00
    +3.40 (+0.18%)
     
  • NASDAQ

    12,606.33
    +329.54 (+2.68%)
     
  • FTSE

    7,585.46
    +20.54 (+0.27%)
     
  • Dow Jones

    33,001.74
    +364.55 (+1.12%)
     
  • DAX

    14,462.19
    +230.90 (+1.62%)
     
  • Hang Seng

    20,697.36
    +581.16 (+2.89%)
     
  • NIKKEI 225

    26,781.68
    +176.84 (+0.66%)
     
  • NZD/JPY

    83.0030
    +0.6860 (+0.83%)
     

3 Reasons to Buy This Newly Minted Dividend King

·4-min read
3 Reasons to Buy This Newly Minted Dividend King

Last month, the diversified healthcare company Abbott Laboratories (NYSE: ABT) raised its quarterly dividend 4.4% from $0.45 to $0.47 per share. Abbott seems to be a thriving business based on its growing sales and profitability.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting